Baker Bros. Advisors’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Baker Bros. Advisors’s Portfolio GMDA Stock Details GMDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-610,626	Closed	-$1.55M	–	119
2021 Q4	$1.55M	Hold	610,626	–	–	0.01%	110
2021 Q3	$2.39M	Hold	610,626	–	–	0.01%	107
2021 Q2	$3.91M	Sell	610,626 -426,600	-41%	-$2.94M	0.02%	100
2021 Q1	$8.39M	Sell	1,037,226 -511,088	-33%	-$4.69M	0.04%	83
2020 Q4	$13M	Buy	1,548,314 +914,990	+144%	+$6.19M	0.05%	68
2020 Q3	$2.63M	Sell	633,324 -33,342	-5%	-$142K	0.01%	97
2020 Q2	$3.05M	Buy	+666,666	New	+$3.06M	0.01%	88

Other funds holding GMDA

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Baker Bros. Advisors's GMDA Position: Q1 2022 in Review

Baker Bros. Advisors sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q1 2022, closing a stake of 610,626 shares — an estimated $1.55M sold.

Baker Bros. Advisors first reported a position in GMDA in Q2 2020 and held it in 7 quarters. The position peaked at $13M in Q4 2020. 59 funds tracked by Wall St. Rank hold GMDA as of Q1 2022.

Baker Bros. Advisors reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Baker Bros. Advisors sold 610,626 Gamida Cell Ltd. Ordinary Shares shares in Q1 2022, an estimated $1.55M.
Baker Bros. Advisors first reported a position in Gamida Cell Ltd. Ordinary Shares in Q2 2020 and held it in 7 quarters.
Baker Bros. Advisors's Gamida Cell Ltd. Ordinary Shares position peaked at $13M in Q4 2020.
59 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q1 2022.

Based on Baker Bros. Advisors's 13F filing for Q1 2022, filed 16 May 2022.